BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19689997)

  • 1. Relation of soluble endothelial protein C receptor and cytokines after allogeneic hematopoietic stem cell transplantation.
    Azik FM; Ertem M; Ileri T; Ince EU; Uysal Z; Egin Y; Akar N
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):94-9. PubMed ID: 19689997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between cytokines, soluble endothelial protein C receptor, and factor VIII levels in Turkish pediatric stroke patients.
    Yürürer D; Teber S; Deda G; Egin Y; Akar N
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):545-51. PubMed ID: 18591180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation.
    Min CK; Lee WY; Min DJ; Lee DG; Kim YJ; Park YH; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2001 Nov; 28(10):935-40. PubMed ID: 11753547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production during myeloablative and reduced intensity therapy before allogeneic stem cell transplantation.
    Remberger M; Sundberg B
    Haematologica; 2004 Jun; 89(6):710-6. PubMed ID: 15194539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation].
    Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.
    Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
    Fowler DH; Odom J; Steinberg SM; Chow CK; Foley J; Kogan Y; Hou J; Gea-Banacloche J; Sportes C; Pavletic S; Leitman S; Read EJ; Carter C; Kolstad A; Fox R; Beatty GL; Vonderheide RH; Levine BL; June CH; Gress RE; Bishop MR
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1150-60. PubMed ID: 17085308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations.
    McGuire TR; Bociek GR; Pavletic SZ; Hock L; Lynch J; Schneider J; Hoie EB; Tarantolo S; Haire WD
    Bone Marrow Transplant; 2001 Nov; 28(9):889-93. PubMed ID: 11781651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation.
    Andersen J; Heilmann C; Jacobsen N; Nielsen C; Bendtzen K; Müller K
    Bone Marrow Transplant; 2006 Apr; 37(7):635-40. PubMed ID: 16474409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.
    Kharbanda S; Panoskaltsis-Mortari A; Haddad IY; Blazar BR; Orchard PJ; Cornfield DN; Grewal SS; Peters C; Regelmann WE; Milla CE; Baker KS
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):430-7. PubMed ID: 16545727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
    Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Dickmeiss E; Vindeløv LL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):48-60. PubMed ID: 16399568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble endothelial protein C receptor: influence on arteriovenous fistula thrombosis development in hemodialysis patients.
    Bilgic A; Ozdemir FN; Bayraktar N; Karakus S; Sasak G; Arat Z; Sezer S; Haberal M
    Am J Nephrol; 2007; 27(4):366-72. PubMed ID: 17570903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation.
    Pihusch R; Höhnberg B; Salat C; Pihusch M; Hiller E; Kolb HJ
    Ann Hematol; 2002 Aug; 81(8):454-61. PubMed ID: 12224003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.
    McNeer JL; Kletzel M; Rademaker A; Alford K; O'Day K; Schaefer C; Duerst R; Jacobsohn DA
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):350-7. PubMed ID: 20005964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
    Hanenberg H; Dilloo D; Laws HJ; Zessack N; Heyll A; Burdach S
    Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.